CompletedPhase 1Phase 2

Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer

NCT00887575

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Holy Cross Hospital

Fort Lauderdale, Florida, United States

+13 additional locations

Save this trial

Holy Cross HospitalFort Lauderdale, Florida, United States
Florida Cancer Specialists NorthFort Myers, Florida, United States
Florida Cancer Specialists SouthFort Myers, Florida, United States
Northeast Georgia Medical CenterGainesville, Georgia, United States
Providence Medical GroupTerre Haute, Indiana, United States
Baptist Hospital EastLouisville, Kentucky, United States
Center for Cancer and Blood DisordersBethesda, Maryland, United States
National Capital Clinical Research ConsortiumBethesda, Maryland, United States
St. Louis Cancer CareChesterfield, Missouri, United States
Nebraska Methodist Cancer CenterOmaha, Nebraska, United States
Hematology Oncology Associates of Northern NJMorristown, New Jersey, United States
Cancer Centers of Southwest OklahomaLawton, Oklahoma, United States
Family Cancer CenterCollierville, Tennessee, United States
Tennessee Oncology, PLLCNashville, Tennessee, United States